Literature DB >> 14604958

Biallelic transcriptional activation of oncogenic transcription factors in T-cell acute lymphoblastic leukemia.

Adolfo A Ferrando1, Sabine Herblot, Teresa Palomero, Mark Hansen, Trang Hoang, Edward A Fox, A Thomas Look.   

Abstract

Aberrant expression of transcription factor oncogenes such as HOX11, HOX11L2, TAL1/SCL, LYL1, LMO1, and LMO2 can be detected in lymphoblasts from up to 80% of patients with acute T-cell lymphoblastic leukemia (T-ALL). Transcriptional activation of these oncogenes in leukemic cells typically results from chromosomal rearrangements that place them next to highly active cis-acting transcriptional regulatory elements. However, biallelic activation of TAL1 in some T-ALL cases has been previously proposed. We have used allele-specific mRNA analysis to show that trans-acting mechanisms leading to biallelic overexpression of TAL1 are involved in 10 (42%) of 24 TAL1+ informative T-ALL cases, 2 (17%) of 12 HOX11+ informative cases, and 7 (64%) of 11 LMO2+ informative cases. We propose that aberrant expression of oncogenic transcription factors in a significant fraction of T-ALLs may result from loss of the upstream transcriptional mechanisms that normally down-regulate the expression of these oncogenes during T-cell development.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14604958     DOI: 10.1182/blood-2003-07-2577

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  44 in total

1.  Transcriptional regulatory networks downstream of TAL1/SCL in T-cell acute lymphoblastic leukemia.

Authors:  Teresa Palomero; Duncan T Odom; Jennifer O'Neil; Adolfo A Ferrando; Adam Margolin; Donna S Neuberg; Stuart S Winter; Richard S Larson; Wei Li; X Shirley Liu; Richard A Young; A Thomas Look
Journal:  Blood       Date:  2006-04-18       Impact factor: 22.113

2.  TLX1/HOX11-mediated disruption of primary thymocyte differentiation prior to the CD4+CD8+ double-positive stage.

Authors:  Bronwyn M Owens; Teresa S Hawley; Lisa M Spain; Kristi A Kerkel; Robert G Hawley
Journal:  Br J Haematol       Date:  2006-01       Impact factor: 6.998

3.  Antileukemia Effects of Notch-Mediated Inhibition of Oncogenic PLK1 in B-Cell Acute Lymphoblastic Leukemia.

Authors:  Sankaranarayanan Kannan; Marisa J L Aitken; Shelley M Herbrich; Leonard S Golfman; Mandy G Hall; Duncan H Mak; Jared K Burks; Guangchun Song; Marina Konopleva; Charles G Mullighan; Joya Chandra; Patrick A Zweidler-McKay
Journal:  Mol Cancer Ther       Date:  2019-06-21       Impact factor: 6.261

4.  Targets of the Tal1 transcription factor in erythrocytes: E2 ubiquitin conjugase regulation by Tal1.

Authors:  Jörn Lausen; Ole Pless; Fransisca Leonard; Olga N Kuvardina; Benjamin Koch; Achim Leutz
Journal:  J Biol Chem       Date:  2009-12-22       Impact factor: 5.157

5.  Homo-binding character of LMO2 isoforms and their both synergic and antagonistic functions in regulating hematopoietic-related target genes.

Authors:  Wei Sun; Wen-Wen Shen; Shuang Yang; Fen Hu; Yang Gao; Yu-Huan Qiao; Tian-Hui Zhu
Journal:  J Biomed Sci       Date:  2010-03-27       Impact factor: 8.410

6.  Activation of the LMO2 oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemia.

Authors:  Sunniyat Rahman; Michael Magnussen; Theresa E León; Nadine Farah; Zhaodong Li; Brian J Abraham; Krisztina Z Alapi; Rachel J Mitchell; Tom Naughton; Adele K Fielding; Arnold Pizzey; Sophia Bustraan; Christopher Allen; Teodora Popa; Karin Pike-Overzet; Laura Garcia-Perez; Rosemary E Gale; David C Linch; Frank J T Staal; Richard A Young; A Thomas Look; Marc R Mansour
Journal:  Blood       Date:  2017-03-07       Impact factor: 22.113

7.  TCRα rearrangements identify a subgroup of NKL-deregulated adult T-ALLs associated with favorable outcome.

Authors:  P Villarese; C Lours; A Trinquand; S Le Noir; M Belhocine; L Lhermitte; A Cieslak; M Tesio; A Petit; M LeLorch; S Spicuglia; N Ifrah; H Dombret; A W Langerak; N Boissel; E Macintyre; V Asnafi
Journal:  Leukemia       Date:  2017-06-08       Impact factor: 11.528

8.  Enforced expression of E47 has differential effects on Lmo2-induced T-cell leukemias.

Authors:  Charnise Goodings; Rati Tripathi; Susan M Cleveland; Natalina Elliott; Yan Guo; Yu Shyr; Utpal P Davé
Journal:  Leuk Res       Date:  2014-11-29       Impact factor: 3.156

9.  NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia.

Authors:  Sophie Kusy; Bastien Gerby; Nicolas Goardon; Nathalie Gault; Federica Ferri; Delphine Gérard; Florence Armstrong; Paola Ballerini; Jean-Michel Cayuela; André Baruchel; Françoise Pflumio; Paul-Henri Roméo
Journal:  J Exp Med       Date:  2010-09-20       Impact factor: 14.307

Review 10.  Stem Cell Leukemia: how a TALented actor can go awry on the hematopoietic stage.

Authors:  N C Correia; M-L Arcangeli; F Pflumio; J T Barata
Journal:  Leukemia       Date:  2016-06-13       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.